Starting insulin therapy in type 2 diabetic patients - Does it really matter how?

被引：12

作者：

Davidson, MB ^{[1
]}

机构：

[1] Charles R Drew Univ Med & Sci, Clin Trials Unit, King Drew Med Ctr, Los Angeles, CA 90059 USA

来源：

DIABETES CARE | 2005年 / 28卷 / 02期

关键词：

D O I：

10.2337/diacare.28.2.494

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：494 / 495

页数：2

共 13 条

[1] INSULIN THERAPY IN OBESE, NON-INSULIN-DEPENDENT DIABETES INDUCES IMPROVEMENTS IN INSULIN ACTION AND SECRETION THAT ARE MAINTAINED FOR 2 WEEKS AFTER INSULIN WITHDRAWAL [J].

ANDREWS, WJ ;

VASQUEZ, B ;

NAGULESPARAN, M ;

KLIMES, I ;

FOLEY, J ;

UNGER, R ;

REAVEN, GM .

DIABETES, 1984, 33 (07) :634-642

[2] INTENSIVE CONVENTIONAL INSULIN THERAPY FOR TYPE-II DIABETES - METABOLIC EFFECTS DURING A 6-MONTH OUTPATIENT TRIAL [J].

HENRY, RR ;

GUMBINER, B ;

DITZLER, T ;

WALLACE, P ;

LYON, R ;

GLAUBER, HS .

DIABETES CARE, 1993, 16 (01) :21-31

[3] Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes [J].

Janka, HU ;

Kliebe-Frisch, C ;

Plewe, G ;

Schweitzer, MA ;

Riddle, MC ;

Yki-Jarvinen, H .

DIABETES CARE, 2005, 28 (02) :254-259

[4] Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients -: Variations with increasing levels of HbA1c [J].

Monnier, L ;

Lapinski, H ;

Colette, C .

DIABETES CARE, 2003, 26 (03) :881-885

[5] Initiating insulin therapy in type 2 diabetes - A comparison of biphasic and basal insulin analogs [J].

Raskin, P ;

Hu, P ;

Allen, E ;

Bode, B ;

Hollander, P ;

Garber, A ;

Lewin, A ;

Gabbay, RA .

DIABETES CARE, 2005, 28 (02) :260-265

[6] Beginning insulin treatment of obese patients with evening 70/30 insulin plus glimepiride versus insulin alone [J].

Riddle, MC ;

Schneider, J .

DIABETES CARE, 1998, 21 (07) :1052-1057

[7] The treat-to-target trial - Randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients [J].

Riddle, MC ;

Rosenstock, J ;

Gerich, J .

DIABETES CARE, 2003, 26 (11) :3080-3086

[8] Basal insulin therapy in type 2 diabetes - 28-week comparison of insulin glargine (HOE 901) and NPH insulin [J].

Rosenstock, J ;

Schwartz, SL ;

Clark, CM ;

Park, GD ;

Donley, DW ;

Edwards, MB .

DIABETES CARE, 2001, 24 (04) :631-636

[9] Real world effectiveness of rosiglitazone added to maximal (tolerated) doses of metformin and a sulfonylurea agent - A systematic evaluation of triple oral therapy in a minority population [J].

Roy, R ;

Navar, M ;

Palomeno, G ;

Davidson, MB .

DIABETES CARE, 2004, 27 (07) :1741-1742

[10] Comparison of different insulin regimens in elderly patients with NIDDM [J].

Wolffenbuttel, BHR ;

Sels, JPJE ;

RondasColbers, GJWM ;

Menheere, PPCA ;

Kruseman, ACN .

DIABETES CARE, 1996, 19 (12) :1326-1332

← 1 2 →